STAT5B and neuroblastoma: In addition, in neuroblastoma (z score = 2.46, p = 0.0138) and triple negative breast cancer (z score = 1.99, p = 0.0471), escalated CTL levels suggested more favorable prognosis when STAT5B had relatively low expression (Supplementary Figures S17F–G).